What is the next step for a 36-year-old man presenting with hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hematuria in a 36-Year-Old Man

For a 36-year-old man presenting with hematuria, the next step should be a complete urologic evaluation including confirmation of microscopic hematuria with urinalysis, upper tract imaging with CT urography, and cystoscopy. 1, 2

Initial Assessment

  • Confirm the presence of hematuria with microscopic examination of urinary sediment from a freshly voided, clean-catch, midstream urine specimen (threshold of ≥3 red blood cells per high-power field) 1, 2
  • Exclude benign causes including infection, vigorous exercise, trauma, and medications 3, 2
  • Obtain urine culture to rule out urinary tract infection as a potential cause 2
  • Assess for signs of primary renal disease, including significant proteinuria, dysmorphic red blood cells, red cell casts, or elevated serum creatinine 1, 3

Risk Stratification

  • At 36 years old, this patient is at the threshold for age-related risk for urologic malignancy (AUA guidelines recommend evaluation for patients with asymptomatic microscopic hematuria who are older than 35 years) 1
  • Assess for additional risk factors including smoking history, occupational exposure to chemicals or dyes, history of gross hematuria, and irritative voiding symptoms 3, 2
  • The risk of malignancy in patients with microscopic hematuria ranges from 2.6% to 4%, compared to 30-40% in those with gross hematuria 3, 4

Diagnostic Pathway

If Gross Hematuria:

  • Urgent urologic referral is mandatory due to high risk of underlying malignancy (>10%), even if bleeding is self-limited 3, 4
  • Do not attribute hematuria solely to antiplatelet or anticoagulant therapy if the patient is taking these medications 1, 3

If Microscopic Hematuria:

  • Assess for glomerular versus non-glomerular source 1, 3
  • Glomerular source is likely if there is significant proteinuria, dysmorphic RBCs, red cell casts, or elevated serum creatinine 3
  • Non-glomerular (urologic) source is likely if there are normal-shaped RBCs, minimal or no proteinuria, and normal serum creatinine 3

Recommended Evaluation

  • Upper Tract Imaging: CT urography is the preferred imaging modality for comprehensive evaluation of the upper urinary tract 1, 3
  • Cystoscopy: Direct visualization of the bladder mucosa, urethra, and ureteral orifices 3, 2
  • Laboratory Tests: Serum creatinine to assess renal function 3, 2

Specialist Referral

  • Urologic Referral: Indicated for all patients with gross hematuria, patients with microscopic hematuria at age 36 with risk factors, or if no benign cause is identified 1, 3
  • Nephrology Referral: Consider if there is evidence of glomerular disease (proteinuria, red cell casts, or predominantly dysmorphic RBCs) 3, 2

Follow-up Recommendations

  • If initial evaluation is negative, repeat urinalysis at 6,12,24, and 36 months 3, 2
  • Monitor blood pressure and consider nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding 3, 2
  • Immediate urologic reevaluation is warranted if any of the following occur: gross hematuria, abnormal urinary cytology, or irritative voiding symptoms in the absence of infection 2

Common Pitfalls to Avoid

  • Do not attribute hematuria solely to antiplatelet or anticoagulant therapy without further investigation 1, 3
  • Do not delay urologic referral while waiting for other test results in a patient with gross hematuria 3
  • Do not assume that a single negative urinalysis excludes significant pathology, as hematuria from cancer can be intermittent 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Microscopic Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Hematuria in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hematuria.

Primary care, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.